Business Segment and Geographical Information (Tables)

6 Months Ended

Jun. 27, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information

	Three Months Ended				Six Months Ended
	June 27,		June 29,		June 27,		June 29,
(In millions)	2020		2019		2020		2019
Revenues
Life Sciences Solutions	$	2,602	$	1,710	$	4,376	$	3,317
Analytical Instruments	1,051		1,324		2,152		2,646
Specialty Diagnostics	988		943		1,946		1,900
Laboratory Products and Services	2,787		2,633		5,517		5,146
Eliminations	(511)		(294)		(844)		(568)
Consolidated revenues	6,917		6,316		13,147		12,441
Segment Income (a)
Life Sciences Solutions	1,234		609		1,909		1,170
Analytical Instruments	135		286		306		568
Specialty Diagnostics	214		242		450		484
Laboratory Products and Services	281		345		576		630
Subtotal reportable segments (a)	1,864		1,482		3,241		2,852
Cost of revenues charges, net	(2)		(5)		(4)		(11)
Selling, general and administrative charges, net	(42)		(36)		(48)		(47)
Restructuring and other (costs) income, net	(12)		484		(50)		473
Amortization of acquisition-related intangible assets	(417)		(429)		(842)		(851)
Consolidated operating income	1,391		1,496		2,297		2,416
Interest income (b)	8		60		44		127
Interest expense (b)	(137)		(181)		(263)		(370)
Other (expense) income, net (b)	(9)		18		3		37
Income before income taxes	$	1,253	$	1,393	$	2,081	$	2,210

(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.

(b)The company does not allocate interest or other expense/income, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information

	Three Months Ended				Six Months Ended
	June 27,		June 29,		June 27,		June 29,
(In millions)	2020		2019		2020		2019
Revenues
Life Sciences Solutions	$	2,602	$	1,710	$	4,376	$	3,317
Analytical Instruments	1,051		1,324		2,152		2,646
Specialty Diagnostics	988		943		1,946		1,900
Laboratory Products and Services	2,787		2,633		5,517		5,146
Eliminations	(511)		(294)		(844)		(568)
Consolidated revenues	6,917		6,316		13,147		12,441
Segment Income (a)
Life Sciences Solutions	1,234		609		1,909		1,170
Analytical Instruments	135		286		306		568
Specialty Diagnostics	214		242		450		484
Laboratory Products and Services	281		345		576		630
Subtotal reportable segments (a)	1,864		1,482		3,241		2,852
Cost of revenues charges, net	(2)		(5)		(4)		(11)
Selling, general and administrative charges, net	(42)		(36)		(48)		(47)
Restructuring and other (costs) income, net	(12)		484		(50)		473
Amortization of acquisition-related intangible assets	(417)		(429)		(842)		(851)
Consolidated operating income	1,391		1,496		2,297		2,416
Interest income (b)	8		60		44		127
Interest expense (b)	(137)		(181)		(263)		(370)
Other (expense) income, net (b)	(9)		18		3		37
Income before income taxes	$	1,253	$	1,393	$	2,081	$	2,210

(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.

(b)The company does not allocate interest or other expense/income, net to its segments.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

Geographical Information

	Three Months Ended				Six Months Ended
	June 27,		June 29,		June 27,		June 29,
(In millions)	2020		2019		2020		2019
Revenues (c)
United States	$	3,414	$	3,103	$	6,553	$	6,021
China	594		724		1,058		1,378
Other	2,909		2,489		5,536		5,042
Consolidated revenues	$	6,917	$	6,316	$	13,147	$	12,441

(c)  Revenues are attributed to countries based on customer location.